1~E11,均經波譜技術確證結構。藥理結果表明,11個化合物均對HepG2細胞呈現不同程度的調血脂活性,其中化合物E10的調血脂活性與陽性藥辛伐他汀相當。結論 化合物E1~E11均為未見文獻報道的肉桂酰苯乙胺類新化合物,具有潛在的調血脂生物活性,值得進一步深入研究。;Objective To design and synthesize the phenylethyl cinnamide compounds, and to study their lipid-regulating activities. Methods Tyramine was used as starting material to synthesize the target compounds by four steps. The lipid-regulating activities of the compounds were tested by HepG2 cells. Results Eleven phenylethyl cinnamide compounds E1 —E11 were synthesized. The structures of the target compounds were identified by spectrum. Pharmacological results showed that all of the compounds had different extents potency of lipid-regulating effects in cells. In particular, compound E10 showed equivalent lipid-regulating effects compared to positive drug simvastatin. Conclusion The compounds E1 —E11 are new phenylethyl cinnamide compounds, which have potential lipid-regulating biological activities, worthy of further development."/>